See more : Digital Health Acquisition Corp. (DHACW) Income Statement Analysis – Financial Results
Complete financial analysis of Chemed Corporation (CHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chemed Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Elcora Advanced Materials Corp. (ECORF) Income Statement Analysis – Financial Results
- Meribank Biotech Co., Ltd (4724.TWO) Income Statement Analysis – Financial Results
- American Education Center, Inc. (AMCT) Income Statement Analysis – Financial Results
- Fujian Qingshan Paper Industry Co.,Ltd. (600103.SS) Income Statement Analysis – Financial Results
- Coenzyme-A Inc. (PPII) Income Statement Analysis – Financial Results
Chemed Corporation (CHE)
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.26B | 2.13B | 2.14B | 2.08B | 1.94B | 1.78B | 1.67B | 1.58B | 1.54B | 1.46B | 1.41B | 1.43B | 1.36B | 1.28B | 1.19B | 1.15B | 1.10B | 1.02B | 926.48M | 735.34M | 308.87M | 314.18M | 477.12M | 500.69M | 453.60M | 381.30M | 341.70M | 683.80M | 699.20M | 645.00M | 525.10M | 401.00M | 352.30M | 599.40M | 591.80M | 500.60M | 391.00M | 359.50M | 372.70M |
| Cost of Revenue | 1.47B | 1.37B | 1.37B | 1.38B | 1.32B | 1.23B | 1.15B | 1.12B | 1.09B | 1.03B | 1.01B | 1.03B | 970.48M | 906.02M | 834.57M | 810.55M | 767.07M | 730.12M | 651.84M | 507.08M | 182.81M | 186.29M | 295.48M | 295.54M | 269.80M | 230.50M | 206.00M | 436.50M | 457.40M | 422.60M | 344.90M | 259.60M | 227.00M | 315.20M | 309.00M | 244.20M | 162.30M | 147.40M | 152.90M |
| Gross Profit | 796.55M | 765.09M | 769.80M | 701.39M | 617.43M | 554.00M | 516.19M | 461.45M | 455.78M | 421.61M | 404.52M | 396.72M | 385.49M | 374.53M | 355.66M | 338.39M | 332.99M | 288.46M | 274.64M | 228.26M | 126.06M | 127.89M | 181.64M | 205.15M | 183.80M | 150.80M | 135.70M | 247.30M | 241.80M | 222.40M | 180.20M | 141.40M | 125.30M | 284.20M | 282.80M | 256.40M | 228.70M | 212.10M | 219.80M |
| Gross Profit Ratio | 35.18% | 35.84% | 35.98% | 33.73% | 31.85% | 31.08% | 30.97% | 29.26% | 29.53% | 28.95% | 28.62% | 27.74% | 28.43% | 29.25% | 29.88% | 29.45% | 30.27% | 28.32% | 29.64% | 31.04% | 40.81% | 40.71% | 38.07% | 40.97% | 40.52% | 39.55% | 39.71% | 36.17% | 34.58% | 34.48% | 34.32% | 35.26% | 35.57% | 47.41% | 47.79% | 51.22% | 58.49% | 59.00% | 58.98% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 322.92M | 358.73M | 366.73M | 330.22M | 305.71M | 270.21M | 276.65M | 243.57M | 237.82M | 220.12M | 212.52M | 208.66M | 202.26M | 201.96M | 197.43M | 175.33M | 184.06M | 161.18M | 151.67M | 138.29M | 105.90M | 95.51M | 146.71M | 148.23M | 136.90M | 113.40M | 100.90M | 197.20M | 190.60M | 177.60M | 143.90M | 117.00M | 107.70M | 226.40M | 211.60M | 194.20M | 169.50M | 159.10M | 162.50M |
| Selling & Marketing | 72.20M | 68.60M | 62.10M | 54.40M | 49.50M | 47.00M | 40.90M | 37.20M | 36.40M | 32.80M | 31.00M | 29.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 395.12M | 358.73M | 366.73M | 330.22M | 305.71M | 270.21M | 276.65M | 243.57M | 237.82M | 220.12M | 212.52M | 208.66M | 202.26M | 201.96M | 197.43M | 175.33M | 184.06M | 161.18M | 151.67M | 138.29M | 105.90M | 95.51M | 146.71M | 148.23M | 136.90M | 113.40M | 100.90M | 197.20M | 190.60M | 177.60M | 143.90M | 117.00M | 107.70M | 226.40M | 211.60M | 194.20M | 169.50M | 159.10M | 162.50M |
| Other Expenses | 60.87M | 62.86M | 60.04M | -18.51M | 54.34M | 287.00K | 8.43M | 2.06M | -270.00K | 3.19M | 4.94M | 3.66M | 29.50M | 29.04M | 31.89M | 27.51M | 26.18M | 22.30M | 43.58M | 31.87M | 12.05M | 13.59M | 16.11M | 23.45M | 20.10M | 17.30M | 15.20M | 18.80M | 18.20M | 15.80M | 13.10M | 9.20M | 8.10M | 23.10M | 21.70M | 19.30M | 16.50M | 14.60M | 13.90M |
| Operating Expenses | 455.99M | 421.59M | 426.77M | 311.71M | 360.05M | 310.37M | 403.16M | 282.70M | 271.32M | 253.19M | 244.91M | 240.30M | 231.76M | 231.01M | 229.32M | 205.54M | 210.24M | 183.49M | 195.25M | 170.16M | 117.95M | 109.10M | 162.82M | 171.68M | 157.00M | 130.70M | 116.10M | 216.00M | 208.80M | 193.40M | 157.00M | 126.20M | 115.80M | 249.50M | 233.30M | 213.50M | 186.00M | 173.70M | 176.40M |
| Cost & Expenses | 1.92B | 1.79B | 1.80B | 1.69B | 1.68B | 1.54B | 1.55B | 1.40B | 1.36B | 1.29B | 1.25B | 1.27B | 1.20B | 1.14B | 1.06B | 1.02B | 977.30M | 913.61M | 847.09M | 677.24M | 300.76M | 295.38M | 458.30M | 467.22M | 426.80M | 361.20M | 322.10M | 652.50M | 666.20M | 616.00M | 501.90M | 385.80M | 342.80M | 564.70M | 542.30M | 457.70M | 348.30M | 321.10M | 329.30M |
| Interest Income | 6.27M | 355.00K | 377.00K | 757.00K | 513.00K | 671.00K | 427.00K | 383.00K | 281.00K | 0.00 | 847.00K | 809.00K | 426.00K | 444.00K | 423.00K | 743.00K | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 3.11M | 4.58M | 1.87M | 2.36M | 4.54M | 4.99M | 4.27M | 3.72M | 3.65M | 8.22M | 15.04M | 14.72M | 13.89M | 11.96M | 11.60M | 5.99M | 11.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 60.87M | 59.17M | 59.05M | 56.58M | 45.21M | 38.86M | 35.63M | 34.64M | 33.50M | 33.07M | 32.39M | 30.52M | 29.50M | 29.04M | 27.90M | 27.51M | 26.57M | 23.80M | 23.34M | 20.18M | 12.81M | 14.36M | 24.12M | 23.45M | 20.10M | 17.30M | 15.20M | 18.80M | 18.20M | 15.80M | 13.10M | 9.20M | 8.10M | 23.10M | 21.70M | 19.30M | 16.50M | 14.60M | 13.90M |
| EBITDA | 414.34M | 393.44M | 411.23M | 454.93M | 311.35M | 283.45M | 156.81M | 215.41M | 217.27M | 200.62M | 162.17M | 191.06M | 183.94M | 174.83M | 160.12M | 155.84M | 138.47M | 126.28M | 99.68M | 78.14M | 18.60M | 27.72M | 37.23M | 52.94M | 46.90M | 37.40M | 34.80M | 29.20M | 51.20M | 44.80M | 36.30M | 24.40M | 17.60M | 57.80M | 71.20M | 62.20M | 59.20M | 53.00M | 57.30M |
| EBITDA Ratio | 18.30% | 18.43% | 19.22% | 21.88% | 16.06% | 15.90% | 9.45% | 13.69% | 14.12% | 14.06% | 13.99% | 13.38% | 13.51% | 13.48% | 12.96% | 13.56% | 14.83% | 12.40% | 13.80% | 12.47% | 8.25% | 16.01% | 13.92% | 10.07% | 7.91% | 4.88% | 4.62% | 2.21% | 4.96% | 5.47% | 3.87% | 2.47% | 0.62% | 9.19% | 11.41% | 11.95% | 14.32% | 17.80% | 13.31% |
| Operating Income | 340.57M | 343.50M | 343.04M | 389.68M | 257.38M | 243.63M | 113.04M | 178.75M | 184.46M | 168.42M | 133.39M | 156.42M | 153.73M | 143.52M | 126.35M | 132.86M | 122.76M | 104.98M | 79.38M | 58.11M | -7.72M | -1.55M | 18.82M | 33.47M | 26.80M | 20.10M | 19.60M | 31.30M | 33.00M | 29.00M | 23.20M | 15.20M | 9.50M | 34.70M | 49.50M | 42.90M | 42.70M | 38.40M | 43.40M |
| Operating Income Ratio | 15.04% | 16.09% | 16.04% | 18.74% | 13.28% | 13.67% | 6.78% | 11.34% | 11.95% | 11.56% | 9.44% | 10.94% | 11.34% | 11.21% | 10.62% | 11.56% | 11.16% | 10.31% | 8.57% | 7.90% | -2.50% | -0.49% | 3.94% | 6.68% | 5.91% | 5.27% | 5.74% | 4.58% | 4.72% | 4.50% | 4.42% | 3.79% | 2.70% | 5.79% | 8.36% | 8.57% | 10.92% | 10.68% | 11.64% |
| Total Other Income/Expenses | 9.80M | -13.82M | 7.28M | 6.31M | 4.23M | -4.03M | 3.88M | -1.70M | -4.33M | -5.67M | -9.57M | -12.94M | -13.17M | -9.69M | -5.73M | -10.51M | -20.92M | -14.70M | -24.73M | -21.02M | 7.67M | -18.42M | -29.15M | -2.54M | 4.20M | 12.00M | 8.30M | 11.00M | 3.00M | -3.50M | 3.20M | 5.60M | 6.90M | -7.70M | -8.10M | -8.60M | -5.60M | -22.60M | -2.90M |
| Income Before Tax | 350.37M | 329.68M | 350.31M | 395.99M | 261.61M | 239.60M | 116.92M | 177.05M | 180.13M | 162.75M | 123.83M | 145.82M | 140.56M | 133.83M | 120.62M | 122.35M | 101.84M | 90.28M | 57.28M | 37.09M | 1.25M | -1.28M | -10.06M | 33.25M | 31.00M | 32.10M | 27.90M | 53.60M | 36.00M | 25.50M | 26.40M | 20.80M | 16.40M | 27.00M | 41.40M | 34.30M | 37.10M | 15.80M | 40.50M |
| Income Before Tax Ratio | 15.47% | 15.44% | 16.38% | 19.04% | 13.50% | 13.44% | 7.01% | 11.23% | 11.67% | 11.18% | 8.76% | 10.20% | 10.37% | 10.45% | 10.13% | 10.65% | 9.26% | 8.86% | 6.18% | 5.04% | 0.40% | -0.41% | -2.11% | 6.64% | 6.83% | 8.42% | 8.17% | 7.84% | 5.15% | 3.95% | 5.03% | 5.19% | 4.66% | 4.50% | 7.00% | 6.85% | 9.49% | 4.39% | 10.87% |
| Income Tax Expense | 77.86M | 80.06M | 81.76M | 76.52M | 41.69M | 34.06M | 18.74M | 68.31M | 69.85M | 63.44M | 46.60M | 56.52M | 54.58M | 52.00M | 46.58M | 50.24M | 39.06M | 32.56M | 19.58M | 13.80M | 4.75M | 6.85M | -3.36M | 12.66M | 11.30M | 12.20M | 10.80M | 21.90M | 15.60M | 11.00M | 9.30M | 6.50M | 5.40M | 10.40M | 15.20M | 13.70M | 16.70M | 9.00M | 18.60M |
| Net Income | 272.51M | 249.62M | 268.55M | 319.47M | 219.92M | 205.54M | 98.18M | 108.74M | 110.27M | 99.32M | 77.23M | 89.30M | 85.98M | 81.83M | 73.78M | 71.02M | 63.98M | 50.65M | 35.82M | 27.51M | -3.44M | -1.81M | -10.38M | 20.58M | 19.70M | 19.90M | 30.30M | 32.30M | 23.10M | 43.90M | 19.50M | 15.70M | 52.90M | 16.60M | 26.20M | 21.90M | 20.40M | 36.80M | 21.90M |
| Net Income Ratio | 12.03% | 11.69% | 12.55% | 15.36% | 11.34% | 11.53% | 5.89% | 6.90% | 7.14% | 6.82% | 5.46% | 6.24% | 6.34% | 6.39% | 6.20% | 6.18% | 5.82% | 4.97% | 3.87% | 3.74% | -1.11% | -0.58% | -2.17% | 4.11% | 4.34% | 5.22% | 8.87% | 4.72% | 3.30% | 6.81% | 3.71% | 3.92% | 15.02% | 2.77% | 4.43% | 4.37% | 5.22% | 10.24% | 5.88% |
| EPS | 18.11 | 16.72 | 17.14 | 20.02 | 13.77 | 12.80 | 6.11 | 6.64 | 6.54 | 5.79 | 4.24 | 4.72 | 4.19 | 3.62 | 3.29 | 3.08 | 2.61 | 1.94 | 1.40 | 1.14 | -0.17 | -0.09 | -0.53 | 1.01 | 0.93 | 0.99 | 1.52 | 1.65 | 1.18 | 2.23 | 1.00 | 0.80 | 2.64 | 0.80 | 1.31 | 1.19 | 1.14 | 2.06 | 1.25 |
| EPS Diluted | 17.93 | 16.53 | 16.85 | 19.48 | 13.31 | 12.23 | 5.86 | 6.48 | 6.33 | 5.57 | 4.16 | 4.62 | 4.10 | 3.55 | 3.24 | 3.04 | 2.55 | 1.90 | 1.36 | 1.12 | -0.17 | -0.09 | -0.53 | 1.00 | 0.93 | 0.99 | 1.51 | 1.63 | 1.18 | 2.23 | 1.00 | 0.80 | 2.64 | 0.80 | 1.27 | 1.14 | 1.08 | 1.80 | 1.14 |
| Weighted Avg Shares Out | 15.05M | 14.93M | 15.67M | 15.96M | 15.97M | 16.06M | 16.06M | 16.38M | 16.87M | 17.17M | 18.20M | 18.92M | 20.52M | 22.59M | 22.45M | 23.06M | 24.52M | 26.12M | 25.55M | 24.12M | 19.85M | 19.72M | 19.43M | 19.67M | 20.94M | 20.12M | 19.88M | 19.58M | 19.72M | 19.71M | 19.60M | 19.63M | 20.08M | 20.75M | 20.08M | 18.48M | 17.89M | 17.86M | 17.59M |
| Weighted Avg Shares Out (Dil) | 15.20M | 15.10M | 15.94M | 16.40M | 16.53M | 16.80M | 16.74M | 16.79M | 17.42M | 17.84M | 18.59M | 19.34M | 20.95M | 23.03M | 22.74M | 23.37M | 25.08M | 26.67M | 26.30M | 24.64M | 19.91M | 19.77M | 19.43M | 19.85M | 21.03M | 20.20M | 20.03M | 19.82M | 19.72M | 19.71M | 19.60M | 19.63M | 20.08M | 20.75M | 20.63M | 19.30M | 18.98M | 20.44M | 19.30M |
DVA vs. CHE: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either DaVita HealthCare (DVA) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right...
Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's...
DVA or CHE: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
Chemed Corporation to Present at the BofA Securities 2023 Virtual Home Care Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2023 Virtual Home Care Conference on Monday, December 4, 2023, at 2:10 PM (ET). The presentation will be webcast live and can be accessed, along with...
Chemed: Continues To Compound Shareholder Value At Double-Digit Returns
Chemed Corporation has historically matched long-term returns with minimal drawdown periods and durable economics. CHE has shown significant market growth over the years, compounding returns on shareholder equity. Business returns regularly level >20% in the TTM and CHE is allocating...
Chemed (CHE) Up 4.8% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
DVA vs. CHE: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either DaVita HealthCare (DVA) or Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
Chemed (CHE) Now Trades Above Golden Cross: Time to Buy?
Chemed Corporation (CHE) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, CHE's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Chemtrade Logistics Income Fund (CGIFF) Q3 2023 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q3 2023 Earnings Call Transcript November 15, 2023 10:00 AM ET Company Participants Rohit Bhardwaj - CFO, IR Scott Rook - President, CEO Conference Call Participants Jacob Bout - CIBC Joel Jackson - BMO Capital...
Chemed's (CHE) VITAS Performance Aids, Macro Issues Linger
Chemed (CHE) believes Roto-Rooter is well-positioned for growth and anticipates continued expansion of the segment's market share.
Source: https://incomestatements.info
Category: Stock Reports